Click for best price
Recombinant Hepatitis B Vaccine Market Size, Share 2022
Market Analysis and Insights: Global Recombinant Hepatitis B Vaccine Market
The global Recombinant Hepatitis B Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Hepatitis B Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Hepatitis B Vaccine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Hepatitis B Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Hepatitis B Vaccine market.
Global Recombinant Hepatitis B Vaccine Scope and Market Size
Recombinant Hepatitis B Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Recombinant Hepatitis B Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
10mcg/ml
10mcg/0.5ml
Segment by Application
Newborn
Primary School Students
Adult
By Company
Merck
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Hualan Biological Engineering
NCPC
China National Biotec Group
Dalian Hissen Bio-pharm
Beijing Tiantan Biological
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Recombinant Hepatitis B Vaccine product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Recombinant Hepatitis B Vaccine, with price, sales, revenue, and global market share of Recombinant Hepatitis B Vaccine from 2019 to 2022.
Chapter 3, the Recombinant Hepatitis B Vaccine competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Hepatitis B Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Recombinant Hepatitis B Vaccine market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Hepatitis B Vaccine.
Chapter 13, 14, and 15, to describe Recombinant Hepatitis B Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Recombinant Hepatitis B Vaccine Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Recombinant Hepatitis B Vaccine Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Recombinant Hepatitis B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Market by Application
1.3.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Hepatitis B Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Hepatitis B Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Hepatitis B Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Hepatitis B Vaccine Sales by Region
2.4.1 Global Recombinant Hepatitis B Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Hepatitis B Vaccine by Region (2023-2028)
2.5 Global Recombinant Hepatitis B Vaccine Revenue by Region
2.5.1 Global Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022)
2.5.2 Global Recombinant Hepatitis B Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Hepatitis B Vaccine Sales by Manufacturers
3.1.1 Global Top Recombinant Hepatitis B Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Hepatitis B Vaccine in 2021
3.2 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers
3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Hepatitis B Vaccine Revenue in 2021
3.3 Global Recombinant Hepatitis B Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Hepatitis B Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Hepatitis B Vaccine Sales by Type
4.1.1 Global Recombinant Hepatitis B Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Hepatitis B Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Hepatitis B Vaccine Revenue by Type
4.2.1 Global Recombinant Hepatitis B Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Hepatitis B Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Hepatitis B Vaccine Price by Type
4.3.1 Global Recombinant Hepatitis B Vaccine Price by Type (2017-2022)
4.3.2 Global Recombinant Hepatitis B Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Hepatitis B Vaccine Sales by Application
5.1.1 Global Recombinant Hepatitis B Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Hepatitis B Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Hepatitis B Vaccine Revenue by Application
5.2.1 Global Recombinant Hepatitis B Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Hepatitis B Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Hepatitis B Vaccine Price by Application
5.3.1 Global Recombinant Hepatitis B Vaccine Price by Application (2017-2022)
5.3.2 Global Recombinant Hepatitis B Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Hepatitis B Vaccine Market Size by Type
6.1.1 North America Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
6.1.2 North America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
6.2 North America Recombinant Hepatitis B Vaccine Market Size by Application
6.2.1 North America Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
6.2.2 North America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
6.3 North America Recombinant Hepatitis B Vaccine Market Size by Country
6.3.1 North America Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
6.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Hepatitis B Vaccine Market Size by Type
7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
7.2 Europe Recombinant Hepatitis B Vaccine Market Size by Application
7.2.1 Europe Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
7.2.2 Europe Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
7.3 Europe Recombinant Hepatitis B Vaccine Market Size by Country
7.3.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
7.3.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Type
8.1.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Application
8.2.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Region
8.3.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Recombinant Hepatitis B Vaccine Market Size by Type
9.1.1 Latin America Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
9.2 Latin America Recombinant Hepatitis B Vaccine Market Size by Application
9.2.1 Latin America Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
9.3 Latin America Recombinant Hepatitis B Vaccine Market Size by Country
9.3.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Type
10.1.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Application
10.2.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Country
10.3.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Corporation Information
11.2.2 GlaxoSmithKline Plc Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Plc Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Limited Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Limited Recent Developments
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Corporation Information
11.6.2 Emergent Biosolutions Overview
11.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent Biosolutions Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Serum Institute of India Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
11.9 Hualan Biological Engineering
11.9.1 Hualan Biological Engineering Corporation Information
11.9.2 Hualan Biological Engineering Overview
11.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Biological Engineering Recent Developments
11.10 NCPC
11.10.1 NCPC Corporation Information
11.10.2 NCPC Overview
11.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 NCPC Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NCPC Recent Developments
11.11 China National Biotec Group
11.11.1 China National Biotec Group Corporation Information
11.11.2 China National Biotec Group Overview
11.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 China National Biotec Group Recent Developments
11.12 Dalian Hissen Bio-pharm
11.12.1 Dalian Hissen Bio-pharm Corporation Information
11.12.2 Dalian Hissen Bio-pharm Overview
11.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dalian Hissen Bio-pharm Recent Developments
11.13 Beijing Tiantan Biological
11.13.1 Beijing Tiantan Biological Corporation Information
11.13.2 Beijing Tiantan Biological Overview
11.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Beijing Tiantan Biological Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Hepatitis B Vaccine Industry Chain Analysis
12.2 Recombinant Hepatitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Hepatitis B Vaccine Production Mode & Process
12.4 Recombinant Hepatitis B Vaccine Sales and Marketing
12.4.1 Recombinant Hepatitis B Vaccine Sales Channels
12.4.2 Recombinant Hepatitis B Vaccine Distributors
12.5 Recombinant Hepatitis B Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Hepatitis B Vaccine Industry Trends
13.2 Recombinant Hepatitis B Vaccine Market Drivers
13.3 Recombinant Hepatitis B Vaccine Market Challenges
13.4 Recombinant Hepatitis B Vaccine Market Restraints
14 Key Findings in The Global Recombinant Hepatitis B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 10mcg/ml
Table 3. Major Manufacturers of 10mcg/0.5ml
Table 4. Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Recombinant Hepatitis B Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Recombinant Hepatitis B Vaccine Sales by Region (2023-2028) & (K Units)
Table 9. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Recombinant Hepatitis B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Recombinant Hepatitis B Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Recombinant Hepatitis B Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Recombinant Hepatitis B Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Recombinant Hepatitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Recombinant Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2021)
Table 21. Recombinant Hepatitis B Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Recombinant Hepatitis B Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Recombinant Hepatitis B Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 26. Global Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 27. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2017-2022)
Table 28. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2023-2028)
Table 29. Global Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2023-2028)
Table 33. Recombinant Hepatitis B Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Recombinant Hepatitis B Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 36. Global Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 37. Global Recombinant Hepatitis B Vaccine Sales Share by Application (2017-2022)
Table 38. Global Recombinant Hepatitis B Vaccine Sales Share by Application (2023-2028)
Table 39. Global Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2023-2028)
Table 43. Recombinant Hepatitis B Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Recombinant Hepatitis B Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. North America Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 47. North America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. North America Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. North America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 54. North America Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 55. North America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Merck Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Recent Developments
Table 110. GlaxoSmithKline Plc Corporation Information
Table 111. GlaxoSmithKline Plc Description and Major Businesses
Table 112. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GlaxoSmithKline Plc Recent Developments
Table 115. Pfizer Inc. Corporation Information
Table 116. Pfizer Inc. Description and Major Businesses
Table 117. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Pfizer Inc. Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pfizer Inc. Recent Developments
Table 120. Sanofi Pasteur Corporation Information
Table 121. Sanofi Pasteur Description and Major Businesses
Table 122. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Pasteur Recent Developments
Table 125. CSL Limited Corporation Information
Table 126. CSL Limited Description and Major Businesses
Table 127. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. CSL Limited Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CSL Limited Recent Developments
Table 130. Emergent Biosolutions Corporation Information
Table 131. Emergent Biosolutions Description and Major Businesses
Table 132. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Emergent Biosolutions Recent Developments
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Major Businesses
Table 137. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Serum Institute of India Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Serum Institute of India Recent Developments
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Major Businesses
Table 142. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Johnson & Johnson Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Johnson & Johnson Recent Developments
Table 145. Hualan Biological Engineering Corporation Information
Table 146. Hualan Biological Engineering Description and Major Businesses
Table 147. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Hualan Biological Engineering Recent Developments
Table 150. NCPC Corporation Information
Table 151. NCPC Description and Major Businesses
Table 152. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. NCPC Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. NCPC Recent Developments
Table 155. China National Biotec Group Corporation Information
Table 156. China National Biotec Group Description and Major Businesses
Table 157. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. China National Biotec Group Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. China National Biotec Group Recent Developments
Table 160. Dalian Hissen Bio-pharm Corporation Information
Table 161. Dalian Hissen Bio-pharm Description and Major Businesses
Table 162. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Dalian Hissen Bio-pharm Recent Developments
Table 165. Beijing Tiantan Biological Corporation Information
Table 166. Beijing Tiantan Biological Description and Major Businesses
Table 167. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Beijing Tiantan Biological Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Recombinant Hepatitis B Vaccine Distributors List
Table 173. Recombinant Hepatitis B Vaccine Customers List
Table 174. Recombinant Hepatitis B Vaccine Market Trends
Table 175. Recombinant Hepatitis B Vaccine Market Drivers
Table 176. Recombinant Hepatitis B Vaccine Market Challenges
Table 177. Recombinant Hepatitis B Vaccine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Hepatitis B Vaccine Product Picture
Figure 3. Global Recombinant Hepatitis B Vaccine Market Share by Type in 2021 & 2028
Figure 3. 10mcg/ml Product Picture
Figure 4. 10mcg/0.5ml Product Picture
Figure 5. Global Recombinant Hepatitis B Vaccine Market Share by Application in 2021 & 2028
Figure 6. Newborn
Figure 7. Primary School Students
Figure 8. Adult
Figure 9. Recombinant Hepatitis B Vaccine Report Years Considered
Figure 10. Global Recombinant Hepatitis B Vaccine Sales 2017-2028 (K Units)
Figure 11. Global Recombinant Hepatitis B Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Recombinant Hepatitis B Vaccine Revenue 2017-2028 (US$ Million)
Figure 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Figure 15. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2023-2028)
Figure 16. North America Recombinant Hepatitis B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 17. North America Recombinant Hepatitis B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Recombinant Hepatitis B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Recombinant Hepatitis B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Recombinant Hepatitis B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Recombinant Hepatitis B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Recombinant Hepatitis B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Recombinant Hepatitis B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Recombinant Hepatitis B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Recombinant Hepatitis B Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Recombinant Hepatitis B Vaccine in the World: Market Share by Recombinant Hepatitis B Vaccine Revenue in 2021
Figure 28. Global Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 32. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
Figure 33. North America Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 34. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. North America Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 36. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. North America Recombinant Hepatitis B Vaccine Sales Share by Country (2017-2028)
Figure 38. North America Recombinant Hepatitis B Vaccine Revenue Share by Country (2017-2028)
Figure 39. U.S. Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 42. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
Figure 43. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
Figure 45. Europe Recombinant Hepatitis B Vaccine Sales Share by Country (2017-2028)
Figure 46. Europe Recombinant Hepatitis B Vaccine Revenue Share by Country (2017-2028)
Figure 47. Germany Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. France Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Recombinant Hepatitis B Vaccine Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Share by Region (2017-2028)
Figure 58. China Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. India Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Recombinant Hepatitis B Vaccine Sales Share by Country (2017-2028)
Figure 73. Latin America Recombinant Hepatitis B Vaccine Revenue Share by Country (2017-2028)
Figure 74. Mexico Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Share by Country (2017-2028)
Figure 83. Turkey Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Recombinant Hepatitis B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. Recombinant Hepatitis B Vaccine Value Chain
Figure 87. Recombinant Hepatitis B Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
